Cargando…

Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis

The long non-coding RNA CERS6 antisense RNA 1 (CERS6-AS1) has critical regulatory roles in breast cancer progression. Here, we determined CERS6-AS1 expression in pancreatic ductal adenocarcinoma (PDAC) and the roles of CERS6-AS1 in PDAC carcinogenesis. The mechanisms underlying the regulatory action...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Zhennan, Meng, Fanqi, Li, Shiquan, Zhang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950275/ https://www.ncbi.nlm.nih.gov/pubmed/33581689 http://dx.doi.org/10.18632/aging.202540

Ejemplares similares

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2018)

microRNA-548b suppresses aggressive phenotypes of hepatocellular carcinoma by directly targeting high-mobility group box 1 mRNA
por: Yun, Zhennan, et al.
Publicado: (2019)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer
por: Li, Zhengliang, et al.
Publicado: (2021)

FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
por: Hong, Chen, et al.
Publicado: (2022)

Long non-coding RNA LINC01116 is activated by EGR1 and facilitates lung adenocarcinoma oncogenicity via targeting miR-744-5p/CDCA4 axis
por: Ren, Ping, et al.
Publicado: (2021)

Hsa_circRNA_0000518 facilitates breast cancer development via regulation of the miR‐326/FGFR1 axis
por: Jiang, Jing, et al.
Publicado: (2020)

Long noncoding RNA CERS6‐AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA
por: Bao, Gang, et al.
Publicado: (2019)

TGIF1-Twist1 axis in pancreatic ductal adenocarcinoma
por: Razzaque, Mohammed S., et al.
Publicado: (2020)

Coadaptation fostered by the SLIT2-ROBO1 axis facilitates liver metastasis of pancreatic ductal adenocarcinoma
por: Li, Qing, et al.
Publicado: (2023)

LncRNA PVT1 Facilitates Proliferation, Migration and Invasion of NSCLC Cells via miR-551b/FGFR1 Axis
por: Wang, Xi, et al.
Publicado: (2021)

Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma
por: Fu, Xue-Liang, et al.
Publicado: (2016)

The FGFR2c/PKCε Axis Controls MCL-1-Mediated Invasion in Pancreatic Ductal Adenocarcinoma Cells: Perspectives for Innovative Target Therapies
por: Ranieri, Danilo, et al.
Publicado: (2022)

Long non-coding RNA PCED1B-AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR-411-3p/HIF-1α axis
por: Zhang, Yi, et al.
Publicado: (2021)

Effect and Mechanism of lncRNA CERS6-AS1 on the Biological Behavior of Prostate Cancer Cell
por: Huang, Fu, et al.
Publicado: (2022)

CerS1 but Not CerS5 Gene Silencing, Improves Insulin Sensitivity and Glucose Uptake in Skeletal Muscle
por: Błachnio-Zabielska, Agnieszka U., et al.
Publicado: (2022)

MicroRNA-664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma
por: Izdebska, Wiktoria Maria, et al.
Publicado: (2023)

MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1
por: Cheng, Kai, et al.
Publicado: (2019)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis
por: Xie, Tao, et al.
Publicado: (2022)

Retracted: Effect and Mechanism of lncRNA CERS6-AS1 on the Biological Behavior of Prostate Cancer Cell
por: and Biomechanics, Applied Bionics
Publicado: (2023)

The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
por: Herremans, Kelly M., et al.
Publicado: (2022)

FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction]
Publicado: (2021)

Circular RNA expression in pancreatic ductal adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2019)

FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib
por: Ying, Xihui, et al.
Publicado: (2019)

lncRNA differentiation antagonizing nonprotein coding RNA overexpression accelerates progression and indicates poor prognosis in pancreatic ductal adenocarcinoma
por: Chen, Lei, et al.
Publicado: (2018)

Long non‐coding RNA AFAP1‐AS1/miR‐320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance
por: Yuan, Zhennan, et al.
Publicado: (2018)

Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p
por: Berrout, Jonathan, et al.
Publicado: (2017)

ZFAS1 functions as an oncogenic long non-coding RNA in bladder cancer
por: Yang, Haifan, et al.
Publicado: (2018)

DLX6-AS1: A Long Non-coding RNA With Oncogenic Features
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1(amp)-FGFR2(norm)-FGFR2-IIIc(high) Axis in Diffuse Gastric Cancer
por: Teles, Sara Pinto, et al.
Publicado: (2019)

Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL
por: Zhao, Zhiping, et al.
Publicado: (2020)

Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012)

Enterohepatic bacterial infections dysregulate the FGF15-FGFR4 endocrine axis
por: Romain, Guillaume, et al.
Publicado: (2013)

UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy
por: Liao, Xiwen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_76b83nbasn8rc1cig40gnth2n4